Satomi Ikeuchi

Title: Satomi Ikeuchi: Innovator in Pharmaceutical Development

Introduction

Satomi Ikeuchi is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. Her work focuses on creating effective treatments for serious medical conditions, showcasing her dedication to improving patient outcomes.

Latest Patents

Satomi Ikeuchi holds a patent for a tablet containing a composite with cyclodextrin. This tablet comprises N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea or a pharmaceutically acceptable salt thereof. This formulation is designed as a medicament for treating acute myeloid leukemia (AML). The tablet is characterized by a composite of the active ingredient and hydroxypropyl-β-cyclodextrin in a specific ratio ranging from 1:8 to 1:20. This innovative approach aims to enhance the efficacy and delivery of the medication.

Career Highlights

Satomi Ikeuchi is associated with Ambit Biosciences Corporation, where she continues to contribute to groundbreaking research and development in the pharmaceutical industry. Her expertise in drug formulation and her commitment to advancing medical science have positioned her as a key figure in her field.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Satomi Ikeuchi's work exemplifies the impact of innovation in the pharmaceutical sector. Her patent for a novel tablet formulation highlights her commitment to addressing critical health challenges. Through her contributions, she continues to pave the way for advancements in medical treatments.